Manchester Global Management UK Ltd Purchases 7,490 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Manchester Global Management UK Ltd increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 182,722 shares of the healthcare conglomerate’s stock after acquiring an additional 7,490 shares during the quarter. UnitedHealth Group comprises approximately 12.2% of Manchester Global Management UK Ltd’s holdings, making the stock its largest holding. Manchester Global Management UK Ltd’s holdings in UnitedHealth Group were worth $92,432,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Western Pacific Wealth Management LP boosted its stake in UnitedHealth Group by 2.2% in the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock valued at $456,000 after buying an additional 19 shares in the last quarter. MCF Advisors LLC grew its holdings in shares of UnitedHealth Group by 0.8% during the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock worth $1,304,000 after purchasing an additional 20 shares during the last quarter. Axiom Financial Strategies LLC boosted its position in UnitedHealth Group by 3.6% in the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock valued at $291,000 after buying an additional 20 shares during the last quarter. Richwood Investment Advisors LLC lifted its stake in shares of UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock valued at $2,654,000 after acquiring an additional 20 shares during the period. Finally, 44 Wealth Management LLC boosted its stake in UnitedHealth Group by 1.6% in the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock valued at $662,000 after acquiring an additional 21 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

NYSE:UNH opened at $425.39 on Tuesday. The company has a market capitalization of $389.11 billion, a P/E ratio of 27.44, a P/E/G ratio of 1.37 and a beta of 0.61. The business’s 50-day moving average is $510.91 and its 200 day moving average is $538.77. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $424.81 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter last year, the company earned $6.91 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.97%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is 35.18%.

Analyst Ratings Changes

UNH has been the subject of several research analyst reports. Raymond James reissued a “strong-buy” rating and set a $540.00 target price (down previously from $635.00) on shares of UnitedHealth Group in a research note on Monday. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Truist Financial decreased their target price on UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating for the company in a research note on Monday. Finally, HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research note on Friday, January 10th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and four have given a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $615.24.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.